0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query globaldata hemophilia b recombinant factor replacement therapy argentina drug forecast.Your search for "" gave back 1531823 results.
Some bleeding disorders may be treated with topical products or nasal sprays. Other disorders, including hemophilia, can be treated with factor...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
ELOCTATE, a therapy regimen for the treatment of hemophilia A that uses Fc Fusion to keep Factor VIII circulating in your bloodstream longer...
Catalog:
GIR
January 2023
Price: USD 3,480.00
Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) - Pipeline Review, H1 2020 Summary Global Markets Direct's latest Pharmaceutical and...
Catalog:
Global Markets Direct
June 2020
Price: USD 2,000.00
Market Analysis and Insights: Global Recombinant Protein Drug R & D Market The global Recombinant Protein Drug R & D market is projected to...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Alpha L-Iduronidase - Pipeline Review, H2 2019 Summary Alpha L-Iduronidase (IDUA or EC 3.2.1.76) pipeline Target constitutes close to 12 molecules...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
Some bleeding disorders may be treated with topical products or nasal sprays. Other disorders, including hemophilia, can be treated with factor...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Recombinant plasma protein therapeutics market is driven by various factors such as shift from use of plasma-derived proteins to recombinant...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Alpha-1 Antitrypsin Deficiency (A1AD) - Pipeline Review, H2 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease...
Catalog:
Global Markets Direct
November 2019
Price: USD 2,000.00
The global Recombinant Human Coagulation VIIa market size was valued at USD 1166.6 million in 2023 and is forecast to a readjusted size of USD 1488.4...
Catalog:
GIR
January 2024
Price: USD 3,480.00
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update...
Catalog:
Global Markets Direct
November 2022
Price: USD 2,000.00
The global Acquired Hemophilia Treatment market size was valued at US$ million in 2023. With growing demand in downstream market, the Acquired...
Catalog:
LPI
March 2024
Price: USD 3,660.00
Lysosomal Alpha Glucosidase (Acid Maltase or Aglucosidase Alfa or GAA or EC 3.2.1.20) - Drugs in Development, 2021 Summary According to the recently...
Catalog:
Global Markets Direct
March 2021
Price: USD 3,500.00
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and...
Catalog:
Global Markets Direct
June 2018
Price: USD 2,000.00
The global Plasma-derived Factor VIII market size was valued at US$ 8570.4 million in 2023. With growing demand in downstream market, the Plasma-...
Catalog:
LPI
March 2024
Price: USD 3,660.00
Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022...
Catalog:
Global Markets Direct
November 2022
Price: USD 2,000.00
